ENETS Webinar Header 1920 350px
Webinar

Most frequent confusions in NEN management

This webinar is tailored for healthcare professionals who are new to the field of neuroendocrine tumours (NETs) and looking to expand their understanding of key aspects of NEN management.

Our experts will address common areas of confusion, including the role of immunohistochemistry in differentiating between mixed NENs, neuroendocrine tumours (NETs), and neuroendocrine carcinomas (NECs). They will also discuss the use of PET imaging and the WHO classification in guiding treatment decisions, as well as the role of conventional imaging in identifying primary tumour locations.

Please note: This webinar is intended for HCPs qualified by law to prescribe medicine.

Access to the Zoom webinar is free; however, prior registration is required. Please click “Register for the Zoom Webinar” below to reserve your spot.

Educational Level:

Basic

Keywords:

pathology, radiology, nuclear medicine, unknown primary, diagnosis

Downloads:

Agenda:

Moderator: Eva TIENSUU JANSON, SWE

18:00 – 18:05 Opening – Eva TIENSUU JANSON, SWE

18:05 – 18:15 Immunohistochemistry and functioning status – Marie-Louise VAN VELTHUYSEN, NED

18:15 – 18:25 PET imaging and WHO status – Valentina AMBROSINI, ITA

18:25 – 18:35 Conventional imaging – Damiano CARUSO, ITA

18:35 – 18:45 Primary location – Julien HADOUX, FRA

18:45 – 19:05 Discussion

19:05 – 19:10 Closing – Eva TIENSUU JANSON, SWE

Moderators:

Speakers:

The webinar series is intended for HCPs qualified by law to prescribe medicine.

 
 

Conflict of Interest Disclosure

In line with EACCME® standards, all faculty participating in this webinar have disclosed any potential conflicts of interest. The disclosures are available to all participants before and during the webinar session.

  • Eva TIENSUU JANSON (moderator) has no potential conflict of interest to report
  • Marie-Louise VAN VELTHUYSEN (speaker) has no potential conflict of interest to report
  • Valentina AMBROSINI (speaker) has the following potential conflict(s) of interest to report:
    • Receipt of speaker fees: ESMIT/ESMO/EANM/AAA/Elma Academy
    • Member of: Oncology and theranostic EANM committee, the ESMO faculty staff for NET, ENETS theranostic task force lead
    • Travel grant: Thema supported an educational grant to my hospital later assigned to cover for the travel expenses of my attendance to a conference
  • Damiano CARUSO (speaker) has no potential conflict of interest to report
  • Julien HADOUX, FRA (speaker) has the following potential conflict(s) of interest to report:
    • Honoraria for speaker engagements, advisory roles or funding of continuous medical education: Lilly, AAA, IPSEN, Roche, Pharma Mar, EISAI, Bayer, HRA pharma, ITM
    • Research grants: Novartis, Lilly, Sanofi

 

UEMS- EACCME® Accreditation Statement

The Webinar Most frequent confusions in NEN management, Virtual, Germany 03/06/2025 - 03/06/2025, has been accredited by the European Accreditation Council for Continuing Medical Education (EACCME®) with 1.0 European CME credits (ECMEC®s). Each medical specialist should claim only those hours of credit that he/she actually spent in the educational activity.

Through an agreement between the Union Européenne des Médecins Spécialistes and the American Medical Association, physicians may convert EACCME® credits to an equivalent number of AMA PRA Category 1 CreditsTM. Information on the process to convert EACCME® credit to AMA credit can be found at https://edhub.ama-assn.org/pages/applications.

Live educational activities, occurring outside of Canada, recognised by the UEMS-EACCME® for ECMEC®s are deemed to be Accredited Group Learning Activities (Section 1) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada.